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Many lineage-specific developmental
regulator genes are transcriptionally
primed in embryonic stem (ES) cells; RNA
PolII is bound at their promoters but is
prevented from productive elongation by
the activity of polycomb repressive com-
plexes (PRC) 1 and 2. This epigenetically
poised state is thought to enable ES cells
to rapidly execute multiple differentiation
programs and is recognized by a simulta-
neous enrichment for trimethylation of
lysine 4 and trimethylation of lysine 27 of
histone H3 (bivalent chromatin) across
promoter regions. Here we show that the
chromatin profile of this important cohort
of genes is progressively modified as ES
cells differentiate toward blood-forming
precursors. Surprisingly however, neural
specifying genes, such as Nkx2-2, Nkx2-9,
and Sox1, remain bivalent and primed
even in committed hemangioblasts, as
conditional deletion of PRC1 results in
overt and inappropriate expression of
neural genes in hemangioblasts. These
data reinforce the importance of PRC1 for
normal hematopoietic differentiation and
reveal an unexpected epigenetic plastic-
ity of mesoderm-committed hemangio-
blasts. (Blood. 2011;117(1):83-87)
Introduction
Tractable mouse embryonic stem (ES) cells in which differentia-
tion pathways can be accurately modeled in vitro and in vivo has
revolutionized our understanding of lineage specification1 and
provided critical information on the linear relationships between
precursor cells and their progeny.2-4 Using a well-characterized
model of hematopoietic differentiation,3-5 we have investigated
stage-specific changes in chromatin at specific genes in ES cells
upon mesoderm induction. Undifferentiated ES cells contain
hyperdynamic chromatin6 where much of the genome is tran-
scribed at a low level7 and many developmental regulator genes are
transcriptionally primed and “bivalently marked” with histone
modifications associated with both gene activation (such as trim-
ethylation of lysine 4 of histone 3 [H3K4me3]) and polycomb-
mediated repression (such as trimethylation of lysine 27 of histone
3 [H3K27me3]).8-10 This marking is thought to reflect the
lineage plasticity of ES cells because it is resolved on differen-
tiation (eg, in neural precursors10,11) and regained upon repro-
gramming of differentiated cells to induced pluripotent stem
cells.12 Initial comparisons between ES, hematopoietic stem
cells, and lymphocytes showed reduced chromatin accessibility
and loss of bivalent marking in hematopoietic cells8 but did not
evaluate whether such changes occurred before, coincident
with, or after cells become functionally restricted. By examining
the chromatin status of a panel of genes in intermediate stages of
differentiation, we show here that several lineage-inappropriate
(neural-specifying) genes remain bivalent and transcriptionally
poised in committed hemangioblasts because the removal of
polycomb repressive complex 1 (PRC1) activity results in overt
gene derepression.
Methods
Cell culture and differentiation
Bry-GFP5 and Ring1a//Ring1bfl/fl/Cre-ERT213 ES cells were cultured and
differentiated as described.5 Embryoid bodies were dissociated, stained
using a phycoerythrin-conjugated anti-Flk1 antibody (BD Biosciences) and
cells sorted on GFP (Bra/T) and Flk1 expression by fluorescence-activated
cell sorting (FACS). Hematopoietic potential was tested using colony
assays as described in supplemental Methods (available on the Blood Web
site; see the Supplemental Materials link at the top of the online article).
Epigenetic analysis
Replication timing and gene expression were analyzed using previously
published methods.14 Embryoid bodies were BrdU pulse-labeled before
dissociation and sorting. Chromatin from Bra/T-GFP/Flk1 cells was
immunoprecipitated as described in supplemental Methods.
Results and discussion
Bry-GFP ES cells that carry a GFP reporter under the control of the
mesoderm-associated Brachyury (Bra/T) gene3,5 were differenti-
ated into embryoid bodies and cells representing epiblast (GFP/
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Flk1, day 2.5), early mesoderm (GFP/Flk1, day 3.75), and
hemangioblast stages (GFP/Flk1, day 3.75) of differentiation
were isolated by FACS, as previously described5 (Figure 1A-B)
and verified by expression analysis. Expression of pluripotency-
associated factors declined (Oct4/Pou5f1) or was lost (Rex1/Zfp42,
Sox2) on differentiation, whereas mesoderm-associated genes
(such as Bra/T, Flk1/Kd, and Ikaros/Ikzf5) were induced, and genes
important for neuroectoderm specification were detected only at
low levels (Math1/Atoh1, Nkx2-2, Nkx2-9, and Sox1)15-18 similar
to undifferentiated ES cells (Figure 1B; supplemental Figure
1A). Importantly, epiblast-stage cells readily formed colonies
when replated in ES media (170/1000 cells), but this capacity
was not retained by cells expressing Bra/T-GFP (Figure 1C),
consistent with a loss of pluripotency and commitment to
mesoderm at this stage.
As accessible chromatin domains tend to replicate earlier in
S-phase than heterochromatic condensed domains,19 we used
replication timing analysis to assess dynamic chromatin changes
accompanying differentiation.8,20-22 Temporal replication of ES-
associated (Rex1 and Sox2), mesoderm-associated (Bra/T, Flk1,
Ikaros, and Myf5), and neuroectoderm-associated (Math1, Sox1,
Nkx2-2, and Nkx2-9) genes was evaluated at different stages of
hemangioblast differentiation (Figure 1D; summarized in supple-
mental Figure 1B) using established methods and controls.14 As
anticipated, Rex1 and Sox2 replication was earlier in ES cells
(black lines) than hemangioblasts (red lines), consistent with
Figure 1. Progressive changes in the replication
timing of developmental regulator genes upon me-
sodermal differentiation of ES cells. (A) Isolation of
cells at sequential stages of ES cell induction to
hematopoietic progenitors. Bry-GFP ES cells were
differentiated in embryoid bodies (EB), harvested at
different times and samples isolated by FACS sorting
on the basis of GFP and Flk1 expression.5 (B) Top
panel: GFP (Bra/T) and Flk1 expression by ES cells (day
0) and in dissociated embryoid bodies (2.5, 3.75 days
of differentiation). Bottom panel: Western blot analysis
of Oct4 and Sox2 levels in sequential 3-fold dilutions of
whole cell extracts from ES and FACS-sorted cell
populations a, b, c, and d. Detection with tubulin
antibody is shown as a loading control. (C) Equal
numbers of undifferentiated ES cells and FACS-sorted
differentiated cell populations were replated in ES cell
medium containing LIF for 10 days on feeder layers
and colonies scored after staining with methylene blue.
Data are mean  SD from 2 experiments carried out in
triplicate. *Significantly different numbers of colonies
compared with ES cells (P  .05, Student t test).
(D) Replication timing of control loci (Globin, X141),
ES- (Rex1 and Sox2), mesodermal- (Bra/T, Flk1, Ikaros,
and Myf5), and neural-specific genes (Math1, Sox1,
Nkx2-2, and Nkx2-9) in undifferentiated ES cells (black),
and ES-derived GFP/Flk1 (epiblast, gray), GFP/
Flk1 (mesoderm, green), and GFP/Flk1 (hemangio-
blast, red) samples. The nonexpressed nonbivalent
Myf5 locus replicates late throughout, whereas the
replication profile of Ikaros, a bivalent locus, is variable
(according to developmental stage) but remains early.
For each locus, the abundance of newly replicated
DNA was measured by quantitative real-time polymer-
ase chain reaction (PCR) in 6 cell-cycle fractions:
G1, S1 to S4, and G2/M as described in supplemental
Figure 2. Values are the amount of newly synthesized
DNA, calculated as a percentage of total (sum of all
fractions). Data are mean  SD from 2 or 3 experiments.
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reduced chromatin accessibility and gene expression upon differen-
tiation, whereas replication of constitutively accessible (-Globin)
or heterochromatic (X141) controls remained unaffected. Three
mesoderm-associated genes showed slight (Bra/T, Ikaros) or
significantly (Flk1) advanced replication in response to differentia-
tion, whereas neural-specifying genes either retained early replica-
tion profiles throughout (Nkx2-2, Nkx2-9, and Sox1) or, in the case
of Math1, were delayed progressively upon differentiation (Figure
1D; supplemental Figure 1B). These data showed that, although
mesoderm commitment results in changed epigenetic profiles,
several genes encoding neural specifiers remained early replicating
in hemangioblasts in contrast to lymphocytes and hematopoietic
stem cell lines (FDCPmix A4 and Pax5/ pro-B) characterized
previously8 (summarized in supplemental Figure 1B).
To directly determine whether these promoters were bivalently
marked in hemangioblasts, we performed chromatin immunopre-
cipitation (ChIP) on purified Bra/T-GFP/Flk1 samples, using
antibodies specific for H3K4me3, H3K27me3, and total H3.
Previous reports had shown that the promoters of Bra/T, Flk1,
Ikaros, Math1, Sox1, Nkx2-2, and Nkx2-9 (but not Myf5) are
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Figure 2. Bivalent chromatin and PRC1-mediated
repression of neural genes is retained in hemangio-
blast-committed cells. (A) Analysis of modified his-
tones at the promoters of ES- (Sox2, Oct4, and Rex1;
blue bars), neural- (Math1, Nkx2-2, Nkx2-9, and Sox1;
red bars), mesodermal- (Ikaros, Bra/T, Flk1, and Myf5;
green bars), and control genes (Gapdh, black bar) by
immunoprecipitation of chromatin from FACS-sorted
GFP/Flk1 (hemangioblast) cells using antibodies
specific for H3K4me3 (top panel) or H3K27me3 (bot-
tom panel). Enrichment was measured by quantitative
real-time PCR and is presented relative to total H3. As a
control, IgG (open bars) was used for ChIP in parallel
(values for most genes were low and barely visible).
Data are mean  SD of 4 experiments. Threshold
levels, based on the enrichment at negative control loci
(Myf5 for H3K4me3, Flk1 for H3K27me3), are indicated in
gray. (B) Sequential ChIP analysis of GFP/Flk1 (heman-
gioblast) cells using first anti-H3K4me3 followed by a
second round of immunoprecipitation using anti-H3K27me3
antibody (filled bars) or nonspecific IgG control (open bars).
Genes are color-coded as in panelA. Data are mean SD
of 3 experiments. Threshold levels, based on the enrich-
ment at a negative control locus (Flk1), is indicated in gray.
(C) Domain-wide profiling of histone methylation along the
Nkx2-2 locus; the positions of a conserved upstream
control element (gray), the transcription start site (arrow),
coding regions (black), UTR (light gray), an adjacent gene
(Rik), and PCR amplicons are indicated in the top panel,
where scale 1 kb. Enrichment of H3K4me3 (top) and
H3K27me3 (bottom) across the Nkx2-2 locus was as-
sessed by ChIP using IgG as controls (white bars, barely
visible) in ES and GFP/Flk1 (hemangioblast) cells. Data
are mean SD from 3 experiments. (D) ChIP analysis of
GFP/Flk1 (hemangioblast) samples using anti-Ring1b
antibody (filled bars) or IgG (open bars). Enrichment levels
were measured by real time-PCR and are expressed
relative to 10% input. Genes are color-coded as in panelA.
Data are mean SD from 3 experiments. Threshold lev-
els, based on the enrichment at the expressed (Ring1b)
Flk1 locus, are indicated in gray. (E) Strategy for withdrawal
of Ring1a/Ring1b activity from CreERT2 ES cells, or from
differentiated hemangioblasts, based on tamoxifen treat-
ment (3 days). (F) Quantitative reverse-transcription PCR
analysis of candidate gene expression (color-coded as in
panel A), in Ring1a//Ring1bfl/fl/Cre-ERT2 undifferentiated
ES cells (top panel) or embryoid body-derived Flk1
hemangioblast cells (bottom panel) 3 days after addition of
800nM tamoxifen (Tam) to delete Ring1b (colored bars)
versus untreated controls (white bars). Values were normal-
ized to a housekeeping gene (Hmbs) and expressed as
fold change relative to untreated. Data are mean SD
from 3 experiments. *Significantly up-regulated expression
in tamoxifen-treated samples (P .05, Student t test). (G)
Hematopoietic colony assays were performed in triplicate
for untreated () and tamoxifen-treated () samples;
FACS-sorted Flk1 Ring1a//Ring1bfl/fl/CreERT2 cells
were replated in differentiation medium (Exp1 and Exp2) or
blast medium (Exp2*) with or without tamoxifen for 3 days
before dissociation and scored 6 days after replating in
semisolid hematopoietic medium. *Significantly different
numbers of colonies in treated compared with untreated
samples (P .05, Student t test).
HEMANGIOBLAST-COMMITTED CELLS 85BLOOD, 6 JANUARY 2011  VOLUME 117, NUMBER 1
For personal use only.on February 20, 2018. by guest  www.bloodjournal.orgFrom 
bivalent in mouse ES cells.10 In hemangioblasts, we detected
H3K4me3 at the promoters of expressed genes (Bra/T, Flk1, green,
Figure 2A), whereas H3K4me3/H3K27me3 was codetected at
Ikaros, Sox2, Math1, Sox1, Nkx2-2, and Nkx2-9. Similar bivalent
marking of these genes was observed in CD41-enriched hemato-
poietic progenitor populations (data not shown). Verification that
the neural-associated genes Sox2, Math1, Sox1, Nkx2-2, and
Nkx2-9 contained bivalently marked chromatin was shown by
sequential ChIP9 in which H3K4me3-containing fragments were
enriched by a second round of precipitation with antibodies to
H3K27me3 (Figure 2B). Furthermore, locus-wide profiling of
Nkx2-2, a gene-poor region on mouse chromosome 2 that has
been extensively characterized as a prototype “bivalent domain”
in ES cells,9,23 showed that the distributions of H3K4me3 and
H3K27me3 were largely preserved in Bra/T-GFP/Flk1 heman-
gioblasts (Figure 2C).
Bivalent marking of developmental regulator genes in ES cells
is associated with a primed transcriptional state in which RNA
polymerase II is bound, phosphorylated at Serine 5, but prevented from
elongating by polycomb repressive complexes; removal of PRC1 or
PRC2 results in inappropriate gene up-regulation (derepression).8,23
Abundant PRC1 transcripts (Ring1a, Ring1b, Mel18, and Bmi1) and
Ring1b protein was detected in both undifferentiated ES cells and
cells at successive stages of hemangioblast differentiation (supple-
mental Figure 3A-B) and ChIP analysis showed Ring1b binding at
Math1, Sox1, Nkx2-2, and Nkx2-9 promoters in Bra/T-GFPFlk1
cells (Figure 2D). To ask whether these genes were indeed
functionally primed in mesoderm-committed hemangioblasts, we
used Ring1a-deficient ES cells where PRC1 activity can be
withdrawn on tamoxifen-induced Ring1b removal (CreERT2 cells13;
Figure 2E). Removal of Ring1b in Flk1 hemangioblasts (supple-
mental Figure 3C-D) resulted in overt expression of Nkx2-2,
Nkx2-9, and Sox1 at day 3 (Figure 2F). In contrast to ES cells,
where PRC1 loss also caused an up-regulation of downstream
hematopoietic regulators (such as Scl, Runx1, and Fli; supplemen-
tal Figure 3E top panel), expression of these genes by hemangio-
blasts was unaffected by PRC1 withdrawal (supplemental Figure
3E bottom panel). Taken together, these data show that there is
extensive remodeling of lineage-appropriate genes upon mesoderm
commitment, yet several lineage-inappropriate genes capable of
executing an alternative fate remain bivalent and primed for
expression. Ring1b-depleted Flk1 hemangioblasts were unable to
generate hematopoietic colonies (Figure 2G), a defect that was
evident after a single day of tamoxifen treatment (supplemental
Figure 3F), confirming the importance of PRC1 in the proliferation
and differentiation of stem cells.24
In conclusion, our data demonstrate that many neural-
specifying genes remain bivalently marked and functionally
primed for expression in ES-derived committed hemangio-
blasts. These include Sox1, Nkx2-2, and Nkx2-9 (Figure 2A-B),
Ngn1, Ngn2, and Msx1 (data not shown), and Math1, a gene that,
although bivalent, showed a delayed timing of replication and
insensitivity to PRC1 withdrawal on mesoderm induction. Collec-
tively, these data suggest that hemangioblast precursors may be
much more plastic than has previously been appreciated and argue
that lineage restriction is probably not the result of an abrupt
stage-specific loss of potential (as has been suggested20,25) but
rather reflects a more gradual and progressive decline in accessibil-
ity of multiple lineage-inappropriate genes over time.
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